Grace Mann

Title: Grace Mann: Innovator in ALS Treatment

Introduction

Grace Mann is a notable inventor based in Menlo Park, CA, who has made significant contributions to the field of medicine, particularly in the treatment of amyotrophic lateral sclerosis (ALS). With a focus on innovative pharmaceutical compositions, she has developed methods that could potentially improve the quality of life for patients suffering from this debilitating condition.

Latest Patents

Grace Mann holds 1 patent related to her work on treatments for ALS using a compound known as dazucorilant. The patent discloses methods and compositions for treating patients suffering from ALS through the administration of a heteroaryl ketone fused azadecalin compound. The specific compound, dazucorilant, is described in detail, including its chemical structure and suitable dosages for effective treatment. The administration methods include oral and enteral routes, highlighting the versatility of the pharmaceutical compositions developed.

Career Highlights

Throughout her career, Grace Mann has been associated with Corcept Therapeutics Incorporated, where she has contributed to groundbreaking research and development in the pharmaceutical industry. Her work focuses on creating effective treatments for serious medical conditions, showcasing her commitment to improving patient outcomes.

Collaborations

Grace has collaborated with esteemed colleagues, including Iulia Cristina Tudor and William Guyer, to advance her research and develop innovative solutions for ALS treatment.

Conclusion

Grace Mann's contributions to the field of ALS treatment through her innovative patent on dazucorilant exemplify her dedication to medical research and patient care. Her work continues to inspire advancements in pharmaceutical therapies for serious health conditions.